Raloxifene, a Selective Estrogen Receptor Modulator, Reduces Carrageenan-Induced Acute Inflammation in Normal and Ovariectomized Rats
article
OA: bronze
CC0
Abstract
Raloxifene (RAL) is a selective estrogen receptor modulator presenting tissue-specific agonist activity. The aim of this study was to examine whether RAL has an estrogenic effect on carrageenan-induced acute inflammation. Adult female rats were ovariectomized (OVX) 7 wk before edema or pleurisy to deplete circulating estrogens. Edema formation and selected inflammatory markers in inflamed paw tissue were measured in intact (sham-operated) and OVX rats. Groups of OVX rats were treated with RAL (1, 3, or 10 mg/kg) or 17beta-estradiol (E2, 25 microg/kg), and these treatments began 2 d after surgery and continued until carrageenan paw edema or pleurisy. Ovariectomy amplifies the inflammation, and we found that RAL, as well as E2, attenuates inflammation and tissue damage associated with paw edema and pleurisy. In treated rats, there is a decrease in edema development and formation, and in polymorphonuclear cell infiltration and migration, as shown by myeloperoxidase measurement and cell counting. RAL and E2 treatments decrease cyclooxygenase-2 and inducible nitric oxide synthase expression in inflamed areas and counteract the inhibition of peroxisome proliferators-activated receptor-gamma expression caused by ovariectomy, restoring this receptor protein expression to sham-operated levels and identifying a possible peroxisome proliferators-activated receptor-dependent antiinflammatory effect of these drugs. Moreover, RAL and E2 increase cytoprotective heat shock protein 72 expression, which seems to be closely associated with the remission of the inflammatory reaction. In addition, we confirm the antiinflammatory effect of RAL in male rats, using a single administration of RAL or E2.
My notes (saved in your browser only)
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
References (48)
- W162515504 via openalex
- W1494611500 via openalex
- W1521475135 via openalex
- W1540765995 via openalex
- W1567127662 via openalex
- W1590381197 via openalex
- W1592252967 via openalex
- W1633340712 via openalex
- W1639924204 via openalex
- W1892217938 via openalex
- W1908936515 via openalex
- W1929009802 via openalex
- W1939457687 via openalex
- W1970652854 via openalex
- W1971909806 via openalex
- W1974573191 via openalex
- W1980481528 via openalex
- W1990725138 via openalex
- W1996462445 via openalex
- W1998223853 via openalex
- W2001127228 via openalex
- W2007898062 via openalex
- W2008039212 via openalex
- W2015903618 via openalex
- W2020358486 via openalex
- W2036800888 via openalex
- W2043500156 via openalex
- W2045389096 via openalex
- W2050638589 via openalex
- W2075566426 via openalex
- W2076353960 via openalex
- W2078259729 via openalex
- W2079327627 via openalex
- W2083748640 via openalex
- W2086056327 via openalex
- W2087259528 via openalex
- W2089747387 via openalex
- W2092397820 via openalex
- W2093772735 via openalex
- W2101738855 via openalex
- W2113259481 via openalex
- W2113264115 via openalex
- W2134745341 via openalex
- W2149124957 via openalex
- W2156971618 via openalex
- W2164015929 via openalex
- W2261454648 via openalex
- W2313326603 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK